scispace - formally typeset
D

David A. Pearce

Researcher at Northumbria University

Publications -  405
Citations -  20297

David A. Pearce is an academic researcher from Northumbria University. The author has contributed to research in topics: Batten disease & CLN3. The author has an hindex of 72, co-authored 396 publications receiving 18416 citations. Previous affiliations of David A. Pearce include University of Zurich & University of York.

Papers
More filters
Journal ArticleDOI

Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons.

TL;DR: A novel path of degeneration within the LGNd is defined, providing a mechanism for causation of JNCL visual deficits, and decreased transport of amino acids from the retina to the L GN is demonstrated, suggesting an impediment in communication between the retina and projection nuclei.
Journal ArticleDOI

Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis

TL;DR: An overview of the therapeutic approaches currently being pursued in preclinical and clinical trials to treat different forms of NCL as well as insight to novel therapeutic approaches in development for the NCLs are provided.
Journal ArticleDOI

Human immunodeficiency virus type 1 Vpr contains two leucine-rich helices that mediate glucocorticoid receptor coactivation independently of its effects on G(2) cell cycle arrest.

TL;DR: It is demonstrated that Vpr functions as a GR coactivator and that this activity is independent of cell cycle arrest, and that the Vpr-induced coactivation requires an intact glucocorticoid response element and is mediated by the two highly conserved leucine-rich domains within Vpr that resemble the GR coActivator signature motif.
Journal ArticleDOI

Differential activities of glucocorticoid-induced leucine zipper protein isoforms.

TL;DR: GILZ inhibition of ERK appears to play an essential role in stimulation of cell surface ENaC but not in inhibition of proliferation, and rat and mouse tissues all expressed multiple GILZ species but varied in the relative abundance of each.
Journal ArticleDOI

Genetic disruption of γ-melanocyte–stimulating hormone signaling leads to salt-sensitive hypertension in the mouse

TL;DR: It is strongly suggested that PC2-dependent processing of POMC into gamma-MSH is necessary for the normal response to the HSD, and a novel pathway mediating salt-sensitivity of blood pressure is demonstrated.